Florey researchers listed in the top 1% for neuroscience and behaviour
Florey researchers listed in the top 1% for neuroscience and behaviour in Highly Cited Researchers list for 2023
Read time:
View more
Florey researchers listed in the top 1% for neuroscience and behaviour in Highly Cited Researchers list for 2023
Read time:
View morePromising results from an initial clinical trial show that sodium ascorbate – a pH-balanced formulation of vitamin C – is effective in treating sepsis.
Read time:
View moreResearchers at The Florey and Austin Health have shown it is possible to detect tell-tale signs of Parkinson’s disease 20-30 years before symptoms appear.
Read time:
View moreScientists at The Florey have discovered a chemical in the brain that may explain the different drinking habits of men and women.
Read time:
View moreResearchers from The Florey say generous funding from FightMND will accelerate development of potential treatments for motor neurone disease.
Read time:
View moreThree researchers have won The Florey's $100K Challenge to develop a method to suppress a harmful protein that builds up in patients with brain diseases.
Read time:
View moreCarolina Gubert has been named Bethlehem Griffiths Research Foundation’s Emerging Researcher of the Year for her research into Huntington’s disease.
Read time:
View moreProfessor Catriona McLean AO was awarded the 2023 Bethlehem Griffiths Research Foundation medal for her remarkable contribution to neuropathology.
Read time:
View morePatients with stroke, as well as clinical teams will benefit from the new, state-of-the-art national registry platform being developed at The Florey.
Read time:
View moreThe Florey's Professor Akhter Hossain has led an international research team in a discovery that could improve drug development for a range of disorders.
Read time:
View moreFlorey scientists’ recent success in Alzheimer’s disease research is a new treatment for the condition.
Read time:
View moreFlorey scientists have joined global MS researchers and identified genetic factors influencing outcomes in people with MS.
Read time:
View moreThe Young Stroke Service is Australia's first digital health service for young people with stroke, aiming to enable patients to live a fulsome life after stroke.
Read time:
View moreResearchers from The Florey will lead a major clinical trial across Australia to test a new treatment for people with sepsis in intensive care units.
Read time:
View moreAccess to advanced diagnostics for people living with epilepsy in South Australia will become a reality as SAHMRI – the state’s independent not-for-profit health and medical research institute – becomes part of the Australian Epilepsy Project (AEP) network.
Read time:
View moreResearchers at The Florey are one step closer to finding new treatments to prevent brain injuries after using a heart-lung machine during heart surgery – a technique used to take over the workload of the heart and lungs, diverting blood and oxygen around the body.
Read time:
View moreAs leaders in brain research for over 50 years The Florey has seen many remarkable discoveries, advances and breakthroughs within our walls. Our teams have been on the forefront of research in conditions including dementia, epilepsy, stroke and anxiety – unravelling the mechanisms driving them and working to provide improved treatments.
The Florey was built upon the research of our founding Director, Professor Derek Denton – whose ground breaking discoveries, in particular those related to salt and water metabolism, have saved countless lives through real time assessment of body chemistry balance post-operatively and in trauma cases. These techniques later evolved into what is now known as intensive care.
More recently however, our achievements include an unexpected discovery about blood flow, with Florey researchers uncovering the previously unknown role of zinc in controlling blood vessels in the body. They found that vessels in the brain were more sensitive to zinc than in the rest of the body – paving the way to develop zinc-based treatments for neurological conditions like Alzheimer’s disease.
Florey researchers were also among the first in the world to warn of the long-term neurological impacts of COVID-19 – with the loss of smell associated with the virus setting off red flags for our Parkinson’s disease team. These same researchers continue to examine the potential link between COVID-19 and increased risk of Parkinson’s disease, working to develop more accurate diagnostic tools to identify neurodegeneration early on and a long-term monitoring approach for people who have been infected with the virus.
The success of The Florey is thanks to our hard-working and dedicated researchers. Their efforts have been recognised with both commonwealth and international honours, specialised awards within their fields, and community recognition and acclaim.
These honours and awards recognise the outstanding efforts and achievements of the individuals and teams who make up The Florey, celebrating the best minds in health and medical research.
Individual awards and careers highlights are listed on individual researcher pages.
Through your generosity, The Florey works to find cures and better ways to tackle complex brain conditions. Your vital contribution enables our scientists to advance brain research, giving people with a brain or mental health condition an improved quality of life.
Donate